Back to News
Market Impact: 0.7

BC Partners to sell $1 billion in Chewy shares, company to repurchase $100m

CHWYJPMUBS
IPOs & SPACsCapital Returns (Dividends / Buybacks)Company FundamentalsCorporate EarningsCorporate Guidance & OutlookAnalyst EstimatesManagement & GovernanceConsumer Demand & Retail
BC Partners to sell $1 billion in Chewy shares, company to repurchase $100m

Chewy's largest shareholder, Buddy Chester Sub LLC, an affiliate of BC Partners, has commenced a $1 billion public offering of Chewy Class A common stock, with an option for an additional $150 million. Chewy will not receive any proceeds from this secondary offering but has agreed to repurchase $100 million of its Class A stock from the selling stockholder at the offering price, a transaction separate from its existing $500 million share repurchase program. This significant share sale by a major investor occurs amid mixed analyst sentiment, with some firms raising price targets on robust customer growth and potential for exceeding revenue guidance, while others maintain neutral or hold ratings due to profitability concerns and valuation.

Analysis

Chewy's largest shareholder, an entity of BC Partners, is conducting a significant secondary offering of $1 billion in Class A stock, a move typical of a private equity sponsor monetizing its position after the stock's 65% appreciation over the past year. While a large insider sale can be perceived negatively, Chewy is actively mitigating this signal by repurchasing $100 million of shares from the offering. This buyback, which is separate from an existing $500 million authorization, demonstrates management's confidence and provides some price support. The transaction occurs amidst a split in analyst sentiment. Bullish firms like JPMorgan and Guggenheim are raising price targets to $47 and $45 respectively, citing robust customer growth and improving profitability, with JPMorgan projecting FY25 sales of $12.45 billion, potentially exceeding guidance. Conversely, UBS and Needham maintain Neutral/Hold ratings due to concerns over profitability and valuation, with UBS revising its FY25 adjusted EBITDA estimate downwards. This divergence frames the central debate: the company's strong top-line momentum and market position against its path to sustained profitability and current valuation.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.